This Viewpoint argues that individualized exposure therapy distinguishing between fear of food vs weight gain is important for successful management of anorexia nervosa.
This Editorial discusses the effectiveness of short-term psychodynamic psychotherapy for major depressive disorder.
This randomized clinical trial explores whether dynamic psychotherapy is not inferior to cognitive therapy in the treatment of major depressive disorder among adults treated in a community mental health center.
This population cohort study uses national Danish registry data to investigate associations between hospitalization with infection and risk of death by suicide.
This cohort study evaluates associations between self-reported physical and emotional abuse in childhood and all-cause mortality rates in adult women.
This randomized trial compares the effects of metformin vs placebo on weight gain in children and adolescents with autism spectrum disorder taking atypical antipsychotics.
This pharmacoepidemiology study examines associations between first-trimester antipsychotic exposure and risk for overall congenital and cardiac malformations among children born to women enrolled in Medicaid.
This randomized clinical trial compares the effects of adjunctive raloxifene with antipsychotic therapy vs antipsychotics alone on illness severity in women with refractory schizophrenia.
This randomized clinical trial examines whether the effects of methylphenidate on the dopaminergic system are modified by age and tests the hypothesis that methylphenidate treatment of young but not adult patients with attention-deficit/hyperactivity disorder induces lasting effects.
This cross-sectional study examines associations between copy number variants associated with intellectual disability and schizophrenia in a search for novel schizophrenia risk loci.
This cohort study examines risk for depression in children and grandchildren stratified by biological parents’ and grandparents’ depression status.
This meta-analysis of trials comparing collaborative to usual care in adults with depression uses individual participant data to investigate if chronic comorbidities modify the effects of the intervention.
This pharmacoepidemiology study uses Medicare Part D data to describe the use of buprenorphine-naloxone in the United States in 2013.
This pharmacoepidemiology study uses BCBS claims data to characterize recent trends in use of methylphenidate and amphetamine-related products in 4 US states between 2010 and 2014.
This study uses UK national survey data to investigate the association between C-reactive protein levels and risk of suicide.
Create a personal account or sign in to: